• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肟类疗法用于有机磷中毒后脑乙酰胆碱酯酶复活及神经保护

Oxime Therapy for Brain AChE Reactivation and Neuroprotection after Organophosphate Poisoning.

作者信息

Kuznetsova Darya A, Gaynanova Gulnara A, Vasilieva Elmira A, Pavlov Rais V, Zueva Irina V, Babaev Vasily M, Kuznetsov Denis M, Voloshina Alexandra D, Petrov Konstantin A, Zakharova Lucia Y, Sinyashin Oleg G

机构信息

Arbuzov Institute of Organic and Physical Chemistry, FRC Kazan Scientific Center, Russian Academy of Sciences, Arbuzov Str. 8, 420088 Kazan, Russia.

出版信息

Pharmaceutics. 2022 Sep 15;14(9):1950. doi: 10.3390/pharmaceutics14091950.

DOI:10.3390/pharmaceutics14091950
PMID:36145698
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9506492/
Abstract

One of the main problems in the treatment of poisoning with organophosphorus (OPs) inhibitors of acetylcholinesterase (AChE) is low ability of existing reactivators of AChE that are used as antidotes to cross the blood-brain barrier (BBB). In this work, modified cationic liposomes were developed that can penetrate through the BBB and deliver the reactivator of AChE pralidoxime chloride (2-PAM) into the brain. Liposomes were obtained on the basis of phosphatidylcholine and imidazolium surfactants. To obtain the composition optimized in terms of charge, stability, and toxicity, the molar ratio of surfactant/lipid was varied. For the systems, physicochemical parameters, release profiles of the substrates (rhodamine B, 2-PAM), hemolytic activity and ability to cause hemagglutination were evaluated. Screening of liposome penetration through the BBB, analysis of 2-PAM pharmacokinetics, and in vivo AChE reactivation showed that modified liposomes readily pass into the brain and reactivate brain AChE in rats poisoned with paraoxon (POX) by 25%. For the first time, an assessment was made of the ability of imidazolium liposomes loaded with 2-PAM to reduce the death of neurons in the brains of mice. It was shown that intravenous administration of liposomal 2-PAM can significantly reduce POX-induced neuronal death in the hippocampus.

摘要

乙酰胆碱酯酶(AChE)有机磷(OPs)抑制剂中毒治疗的主要问题之一是,用作解毒剂的现有AChE复活剂穿越血脑屏障(BBB)的能力较低。在这项研究中,开发了可穿透血脑屏障并将AChE复活剂氯解磷定(2-PAM)递送至脑内的改性阳离子脂质体。脂质体基于磷脂酰胆碱和咪唑鎓表面活性剂制备。为获得在电荷、稳定性和毒性方面优化的组合物,改变了表面活性剂/脂质的摩尔比。对这些体系评估了理化参数、底物(罗丹明B、2-PAM)的释放曲线、溶血活性和引起血凝的能力。脂质体穿越血脑屏障的筛选、2-PAM药代动力学分析及体内AChE复活表明,改性脂质体可轻易进入脑内,并使对氧磷(POX)中毒大鼠脑内的AChE复活25%。首次评估了负载2-PAM的咪唑鎓脂质体减少小鼠脑内神经元死亡的能力。结果表明,静脉注射脂质体2-PAM可显著减少POX诱导的海马神经元死亡。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc7f/9506492/9f705e63ba7c/pharmaceutics-14-01950-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc7f/9506492/ddcd06c679d8/pharmaceutics-14-01950-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc7f/9506492/a6f131814a10/pharmaceutics-14-01950-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc7f/9506492/6bd243fcbaa4/pharmaceutics-14-01950-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc7f/9506492/338f2ae7e4ca/pharmaceutics-14-01950-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc7f/9506492/33d5e7762401/pharmaceutics-14-01950-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc7f/9506492/304ac0972976/pharmaceutics-14-01950-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc7f/9506492/5267c85bdd1f/pharmaceutics-14-01950-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc7f/9506492/551b7f075638/pharmaceutics-14-01950-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc7f/9506492/ff51ef83ccd7/pharmaceutics-14-01950-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc7f/9506492/61716a8c5389/pharmaceutics-14-01950-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc7f/9506492/9f705e63ba7c/pharmaceutics-14-01950-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc7f/9506492/ddcd06c679d8/pharmaceutics-14-01950-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc7f/9506492/a6f131814a10/pharmaceutics-14-01950-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc7f/9506492/6bd243fcbaa4/pharmaceutics-14-01950-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc7f/9506492/338f2ae7e4ca/pharmaceutics-14-01950-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc7f/9506492/33d5e7762401/pharmaceutics-14-01950-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc7f/9506492/304ac0972976/pharmaceutics-14-01950-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc7f/9506492/5267c85bdd1f/pharmaceutics-14-01950-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc7f/9506492/551b7f075638/pharmaceutics-14-01950-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc7f/9506492/ff51ef83ccd7/pharmaceutics-14-01950-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc7f/9506492/61716a8c5389/pharmaceutics-14-01950-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc7f/9506492/9f705e63ba7c/pharmaceutics-14-01950-sch001.jpg

相似文献

1
Oxime Therapy for Brain AChE Reactivation and Neuroprotection after Organophosphate Poisoning.肟类疗法用于有机磷中毒后脑乙酰胆碱酯酶复活及神经保护
Pharmaceutics. 2022 Sep 15;14(9):1950. doi: 10.3390/pharmaceutics14091950.
2
Surface modification of pralidoxime chloride-loaded solid lipid nanoparticles for enhanced brain reactivation of organophosphorus-inhibited AChE: Pharmacokinetics in rat.载氯解磷定固体脂质纳米粒的表面修饰增强有机磷抑制乙酰胆碱酯酶的脑重活化:在大鼠中的药代动力学。
Toxicology. 2020 Nov;444:152578. doi: 10.1016/j.tox.2020.152578. Epub 2020 Sep 6.
3
Mixed cationic liposomes for brain delivery of drugs by the intranasal route: The acetylcholinesterase reactivator 2-PAM as encapsulated drug model.经鼻腔给药脑内递药用混合阳离子脂质体:作为包裹药物模型的乙酰胆碱酯酶重激活剂 2-PAM。
Colloids Surf B Biointerfaces. 2018 Nov 1;171:358-367. doi: 10.1016/j.colsurfb.2018.07.049. Epub 2018 Jul 24.
4
Therapy of Organophosphate Poisoning via Intranasal Administration of 2-PAM-Loaded Chitosomes.通过鼻内给予负载2-吡啶醛肟甲基氯化物的壳聚糖微粒治疗有机磷中毒
Pharmaceutics. 2022 Dec 19;14(12):2846. doi: 10.3390/pharmaceutics14122846.
5
Biomedical potentialities of cationic geminis as modulating agents of liposome in drug delivery across biological barriers and cellular uptake.阳离子双子作为脂质体在生物屏障和细胞摄取中药物传递的调节剂的生物医学潜力。
Int J Pharm. 2020 Sep 25;587:119640. doi: 10.1016/j.ijpharm.2020.119640. Epub 2020 Jul 13.
6
Conjugates of nucleobases with triazole-hydroxamic acids for the reactivation of acetylcholinesterase and treatment of delayed neurodegeneration induced by organophosphate poisoning.核苷与三唑-羟肟酸的缀合物,用于重新激活乙酰胆碱酯酶和治疗有机磷中毒引起的迟发性神经退行性变。
Bioorg Chem. 2023 Dec;141:106858. doi: 10.1016/j.bioorg.2023.106858. Epub 2023 Sep 15.
7
Brain-targeted delivery of obidoxime, using aptamer-modified liposomes, for detoxification of organophosphorus compounds.利用适体修饰的脂质体实现对氧磷酶的脑靶向递送,用于解毒有机磷化合物。
J Control Release. 2021 Jan 10;329:1117-1128. doi: 10.1016/j.jconrel.2020.10.039. Epub 2020 Oct 21.
8
Nanoparticle-Delivered 2-PAM for Rat Brain Protection against Paraoxon Central Toxicity.纳米颗粒递送 2-PAM 对大鼠脑保护对抗对氧磷中央毒性。
ACS Appl Mater Interfaces. 2017 May 24;9(20):16922-16932. doi: 10.1021/acsami.7b04163. Epub 2017 May 15.
9
Pro-2-PAM therapy for central and peripheral cholinesterases.Pro-2-PAM 疗法治疗中枢和周围乙酰胆碱酯酶。
Chem Biol Interact. 2010 Sep 6;187(1-3):191-8. doi: 10.1016/j.cbi.2010.02.015. Epub 2010 Feb 13.
10
Absence of a protective effect of the oxime 2-PAM toward paraoxon-poisoned honey bees: acetylcholinesterase reactivation not at fault.肟类药物2 - PAM对中毒蜜蜂无保护作用:乙酰胆碱酯酶再活化并非原因所在。
Toxicol Appl Pharmacol. 1998 Sep;152(1):184-92. doi: 10.1006/taap.1998.8483.

引用本文的文献

1
Recent Development of Nanoparticle Platforms for Organophosphate Nerve Agent Detoxification.用于有机磷神经毒剂解毒的纳米颗粒平台的最新进展
Langmuir. 2025 Feb 4;41(4):2124-2140. doi: 10.1021/acs.langmuir.4c04637. Epub 2025 Jan 25.
2
Editorial for Special Issue: "Liposomal and Lipid-Based Drug Delivery Systems and Vaccines".特刊社论:“脂质体和基于脂质的药物递送系统与疫苗”
Pharmaceutics. 2024 Feb 6;16(2):238. doi: 10.3390/pharmaceutics16020238.
3
A Pralidoxime Nanocomplex Formulation Targeting Transferrin Receptors for Reactivation of Brain Acetylcholinesterase After Exposure of Mice to an Anticholinesterase Organophosphate.

本文引用的文献

1
Enhancement of the Transdermal Delivery of Nonsteroidal Anti-inflammatory Drugs Using Liposomes Containing Cationic Surfactants.使用含有阳离子表面活性剂的脂质体增强非甾体抗炎药的透皮给药
ACS Omega. 2022 Jul 12;7(29):25741-25750. doi: 10.1021/acsomega.2c03039. eCollection 2022 Jul 26.
2
A Historical Review of Brain Drug Delivery.脑药物递送的历史回顾
Pharmaceutics. 2022 Jun 16;14(6):1283. doi: 10.3390/pharmaceutics14061283.
3
Development of Irinotecan Liposome Armed with Dual-Target Anti-Epidermal Growth Factor Receptor and Anti-Fibroblast Activation Protein-Specific Antibody for Pancreatic Cancer Treatment.
一种靶向转铁蛋白受体的解磷定纳米复合制剂,用于小鼠暴露于抗胆碱酯酶有机磷酸酯后脑乙酰胆碱酯酶的重新激活。
Int J Nanomedicine. 2024 Jan 12;19:307-326. doi: 10.2147/IJN.S443498. eCollection 2024.
4
Mitochondria-Targeted Lipid Nanoparticles Loaded with Rotenone as a New Approach for the Treatment of Oncological Diseases.线粒体靶向载鱼藤酮脂质纳米粒作为治疗肿瘤疾病的新方法。
Molecules. 2023 Oct 23;28(20):7229. doi: 10.3390/molecules28207229.
5
Strategies for enhanced bioavailability of oxime reactivators in the central nervous system.增强肟类重活化剂在中枢神经系统中生物利用度的策略。
Arch Toxicol. 2023 Nov;97(11):2839-2860. doi: 10.1007/s00204-023-03587-0. Epub 2023 Aug 29.
6
Synthesis, Properties, and Biomedical Application of Dicationic Gemini Surfactants with Dodecane Spacer and Carbamate Fragments.含十二烷间隔基和氨基甲酸酯片段的双阳离子 Gemini 表面活性剂的合成、性质及生物医学应用
Int J Mol Sci. 2023 Aug 1;24(15):12312. doi: 10.3390/ijms241512312.
7
Mitochondria-Targeted Delivery Strategy of Dual-Loaded Liposomes for Alzheimer's Disease Therapy.载双药脂质体的线粒体靶向递药策略治疗阿尔茨海默病
Int J Mol Sci. 2023 Jun 22;24(13):10494. doi: 10.3390/ijms241310494.
8
Therapy of Organophosphate Poisoning via Intranasal Administration of 2-PAM-Loaded Chitosomes.通过鼻内给予负载2-吡啶醛肟甲基氯化物的壳聚糖微粒治疗有机磷中毒
Pharmaceutics. 2022 Dec 19;14(12):2846. doi: 10.3390/pharmaceutics14122846.
9
Complexation of Oligo- and Polynucleotides with Methoxyphenyl-Functionalized Imidazolium Surfactants.寡核苷酸和多核苷酸与甲氧基苯基功能化咪唑鎓表面活性剂的络合作用。
Pharmaceutics. 2022 Dec 1;14(12):2685. doi: 10.3390/pharmaceutics14122685.
10
Transdermal Delivery of 2-PAM as a Tool to Increase the Effectiveness of Traditional Treatment of Organophosphate Poisoning.2-PAM 通过透皮给药作为增加传统有机磷中毒治疗效果的工具。
Int J Mol Sci. 2022 Nov 30;23(23):14992. doi: 10.3390/ijms232314992.
用于胰腺癌治疗的、负载双靶点抗表皮生长因子受体和抗成纤维细胞活化蛋白特异性抗体的伊立替康脂质体的研发
Pharmaceutics. 2022 Jun 5;14(6):1202. doi: 10.3390/pharmaceutics14061202.
4
pH-Sensitive Liposomes for Enhanced Cellular Uptake and Cytotoxicity of Daunorubicin in Melanoma (B16-BL6) Cell Lines.用于增强柔红霉素在黑色素瘤(B16 - BL6)细胞系中的细胞摄取及细胞毒性的pH敏感脂质体
Pharmaceutics. 2022 May 26;14(6):1128. doi: 10.3390/pharmaceutics14061128.
5
Formulation of Amphotericin B in PEGylated Liposomes for Improved Treatment of Cutaneous Leishmaniasis by Parenteral and Oral Routes.两性霉素B聚乙二醇化脂质体的制剂,用于通过肠胃外和口服途径改善皮肤利什曼病的治疗。
Pharmaceutics. 2022 May 5;14(5):989. doi: 10.3390/pharmaceutics14050989.
6
Current Strategies to Enhance Delivery of Drugs across the Blood-Brain Barrier.增强药物透过血脑屏障递送的当前策略。
Pharmaceutics. 2022 May 4;14(5):987. doi: 10.3390/pharmaceutics14050987.
7
Recent Advances in the Treatment of Alzheimer's Disease Using Nanoparticle-Based Drug Delivery Systems.基于纳米颗粒的药物递送系统在阿尔茨海默病治疗中的最新进展
Pharmaceutics. 2022 Apr 11;14(4):835. doi: 10.3390/pharmaceutics14040835.
8
Polymer-Modified Liposomes for Drug Delivery: From Fundamentals to Applications.用于药物递送的聚合物修饰脂质体:从基础到应用
Pharmaceutics. 2022 Apr 2;14(4):778. doi: 10.3390/pharmaceutics14040778.
9
Cationic Imidazolium Amphiphiles Bearing a Methoxyphenyl Fragment: Synthesis, Self-Assembly Behavior, and Antimicrobial Activity.带有甲氧基苯基片段的阳离子咪唑鎓两亲物:合成、自组装行为及抗菌活性
Langmuir. 2022 Apr 26;38(16):4921-4934. doi: 10.1021/acs.langmuir.2c00299. Epub 2022 Apr 11.
10
Liposomal Formulation of a PLA2-Sensitive Phospholipid-Allocolchicinoid Conjugate: Stability and Activity Studies In Vitro.PLA2 敏感型磷脂-别秋水仙碱类偶联物的脂质体制剂:体外稳定性和活性研究。
Int J Mol Sci. 2022 Jan 18;23(3):1034. doi: 10.3390/ijms23031034.